Barriers to practicing risk reduction strategies among people who inject drugs

References

• Beletsky, L., Grau, L.E., White, E., Bowman, S., & Heimer, R. (2011). The roles of law, client race and program visibility in shaping police interference with the operation of US syringe exchange programs. Addiction, 106, 357–365
   PubMed Web of Science ®Google Scholar
• Binswanger, I.A., Kral, A.H., Bluthenthal, R.N., Rybold, D.J., & Edlin, B.R. (2000). High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clinical Infectious Diseases, 30, 579–581
   PubMed Web of Science ®Google Scholar
• Bluthenthal, R.N., Malik, M.R., Grau, L.E., Singer, M., Marshall, P., Heimer, R., & the Diffusion of Benefit through Syringe Exchange Study Team. (2004). Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities. Addiction, 99, 1136–1146
   PubMed Web of Science ®Google Scholar
• Bluthenthal, R.N., Ridgeway, G., Schell, T., Anderson, R., Flynn, N.M., & Kral, A.H. (2007). Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injection drug users. Addiction, 102, 638–646
   PubMed Web of Science ®Google Scholar
• Bonar, E.E., & Rosenberg, H. (2014). Injection drug users’ perceived barriers to using self-initiated harm reduction strategies. Addiction Research and Theory, 22, 271–278
   PubMed Web of Science ®Google Scholar
• Chitwood, D., Griffin, D., Comerford, M., Page, J., Trapido, E., Lai, S., & McCoy, C. (1995). Risk factors for HIV-1 seroconversion among injection drug users: A case control study. American Journal of Public Health, 85, 1538–1542
   PubMed Web of Science ®Google Scholar
• Colon, H.M., Finlinson, H.A., Negron, J., Sosa, I., Rios-Olivares, E., & Robles, R.R. (2009). Pilot trial of an intervention aimed at modifying drug preparation practices among injection drug users in Puerto Rico. AIDS and Behavior, 13, 523–531
   PubMed Web of Science ®Google Scholar
• Compton, W.M., Horton, J.C., Cottler, L.B., Booth, R.E., Leukefeld, C.G., Singer, M., … Spitznagel, E.L. (2004). A multistate trial of pharmacy syringe purchase. Journal of Urban Health, 81, 661–670
   PubMed Web of Science ®Google Scholar
• Copenhaver, M.M., Johnson, B.T., Lee, I.C., Harman, J.J., Carey, M.P., & the SHARP Research Team. (2006). Behavioral HIV risk reduction among people who inject drugs: Meta-analytic evidence of efficacy. Journal of Substance Abuse Treatment, 31, 163–171
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D.C., Friedman, S.R., & Hopkins, W. (1985). Risk reduction for the Acquired Immune Deficiency Syndrome among intravenous drug users. Annals of Internal Medicine, 103, 755–759
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D.C., Hagan, H., & Arasteh, K. (2011). Can intranasal drug use reduce HCV infection among injecting drug users? Drug and Alcohol Dependence, 119, 201–206
   PubMed Web of Science ®Google Scholar
• Fraser, S., & Moore, D. (2011). Harm reduction and Hepatitis C: On the ethics and politics of prevention and treatment. Addiction Research & Theory, 19, 375–379
   Web of Science ®Google Scholar
• Friedman, S.R., Des Jarlais, D.C., & Sotheran, J.L. (1986). AIDS health education for intravenous drug users. Health Education Quarterly, 13, 383–393
   PubMedGoogle Scholar
• Friedman, S.R., Sandoval, M., Mateu-Gelabert, P., Meylakhs, P., & Des Jarlais, D.C. (2011). Symbiotic goals and the prevention of blood-borne viruses among injection drug users. Substance Use & Misuse, 46, 307–315
   PubMed Web of Science ®Google Scholar
• Gagnon, H., & Godin, G. (2009). Psychosocial factors explaining drug users’ intention to use a new syringe at each injection. Addiction Research and Theory, 17, 481–492
   Web of Science ®Google Scholar
• Gleghorn, A.A., & Corby, N.H. (1996). Injection drug users’ reactions to guidelines for bleach disinfection of needles and syringes: Implications for HIV prevention. Journal of Drug Issues, 26, 865–881
   Web of Science ®Google Scholar
• Gordon, R.J., & Lowy, F.D. (2005). Bacterial infections in drug users. New England Journal of Medicine, 353, 1945–1954
   PubMed Web of Science ®Google Scholar
• Grund, J.P.C., Friedman, S.R., Stern, L.S., Jose, B., Neaigus, A., Curtis, R., & Des Jarlais, D.C. (1996). Syringe-mediated drug sharing among injecting drug users: Patterns, social context and implications for transmission of blood-borne pathogens. Social Science & Medicine, 42, 691–703
   PubMed Web of Science ®Google Scholar
• Hagan, H., McGough, J.P., Thiede, H., Weiss, N.S., Hopkins, S., & Alexander, E.R. (2000). Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors. Journal of Substance Abuse Treatment, 19, 247–252
   PubMed Web of Science ®Google Scholar
• Hagan, H., Pouget, E.R., Williams, I.T., Garfein, R.L., Strathdee, S.A., Hudson, S.M., … Ouellet, L.J. (2010). Attribution of Hepatitis C virus seroconversion risk in young injection drug users in 5 US cities. Journal of Infectious Diseases, 201, 378–385
   PubMed Web of Science ®Google Scholar
• Hagan, H., Thiede, H., Weiss, N.S., Hopkins, S.G., Duchin, J.S., & Alexander, E.R. (2001). Sharing of drug preparation equipment as a risk factor for hepatitis C. American Journal of Public Health, 91, 42–46
   PubMed Web of Science ®Google Scholar
• Hahn, J.A., Page-Shafer, K., Lum, P.J., Bourgois, P, Stein, E., Evans, J.L., … Moss, A.R. (2002). Hepatitis C Virus seroconversion among young injection drug users: Relationships and risks. Journal of Infectious Diseases, 186, 1558–1564
   PubMed Web of Science ®Google Scholar
• Hammett, T.M., Phan, S., Gaggin, S., Case, P., Zaller, N., Lutnick, A., … Des Jarlais, D.C. (2014). Pharmacies as providers of expanded health services for people who inject drugs: A review of laws, policies, and barriers in six countries. BMC Health Services Research, 14, 261
   PubMed Web of Science ®Google Scholar
• Harm Reduction Coalition. (2012). Getting off right: A safety manual for injection drug users. New York: Harm Reduction Coalition. Retrieved May 20, 2015, from http://www.harmreduction.org
   Google Scholar
• Heimer, R., Khoshnood, K., Bigg, D., Guydish, J., & Junge, B. (1998). Syringe use and reuse: Effects of syringe exchange programs in four cities. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18, S37–S44
   PubMedGoogle Scholar
• Hughes, R.A. (2004). “When you’re using gear you put HIV to the back of your mind and forget about it.”: Constructs of risk. Journal of Psychoactive Drugs, 36, 357–366
   PubMed Web of Science ®Google Scholar
• Huo, D., & Ouellet, L.J. (2007). Needle exchange and injection-related risk behaviors in Chicago: A longitudinal study. Journal of Acquired Immune Deficiency Syndromes, 45, 108–114
   PubMed Web of Science ®Google Scholar
• Kral, A.H., Anderson, R., Flynn, N.M., & Bluthenthal, R.N. (2004). Injection risk behaviors among clients of syringe exchange programs with different syringe dispensation policies. Journal of Acquired Immune Deficiency Syndromes, 37, 1307–1312
   PubMed Web of Science ®Google Scholar
• Latkin, C.A., Mandell, W., Vlahov. D., Knowlton, A.R., Oziemkowska, M., & Celentano, D.D. (1995). Self-reported reasons for needle sharing and not carrying bleach among injection drug users in Baltimore, Maryland. The Journal of Drug Issues, 25, 865–870
   Web of Science ®Google Scholar
• Mateu-Gelabert, P., Sandoval, M., Meylakhs, P., Wendel, T., & Friedman, S.R. (2010). Strategies to avoid opiate withdrawal: Implications for HCV and HIV risks. International Journal of Drug Policy, 21, 179–185
   PubMed Web of Science ®Google Scholar
• Newmeyer, J.A. (1988). Why bleach? Fighting AIDS contagion among intravenous drug users: The San Francisco experience. Journal of Psychoactive Drugs, 20, 159–163
   PubMed Web of Science ®Google Scholar
• Nyamathi, A.M., Lewis, C., Leake, B., Flaskerud, J., & Bennett, C. (1995). Barriers to condom use and needle cleaning among impoverished minority female injection drug users and partners of injection drug users. Public Health Reports, 110, 166–172
   PubMed Web of Science ®Google Scholar
• Patrick, D.M., Strathdee, S.A., Archibald, C.P., Ofner, M., Craib, K.J., Cornelisse, P.G., … O'Shaughnessy, M.V. (1997). Determinants of HIV seroconversion in drug users during a period of rising prevalence in Vancouver. International Journal of STD & AIDS, 8, 437–445
   PubMed Web of Science ®Google Scholar
• Phillips, K.T., Altman, J.K., Corsi, K.F., & Stein, M.D. (2012). Development of a risk reduction intervention to reduce bacterial and viral infections for injection drug users. Substance Use & Misuse, 48, 54–64
   PubMed Web of Science ®Google Scholar
• Phillips, K.T., & Stein, M.D. (2010). Risk practices associated with bacterial infections among injection drug users in Denver, Colorado. The American Journal of Drug and Alcohol Abuse, 36, 92–97
   PubMed Web of Science ®Google Scholar
• Phillips, K.T., Stein, M.D., Anderson, B.J., & Corsi, K.F. (2012). Skin and needle hygiene intervention for injection drug users: Results from a randomized, controlled Stage I pilot trial. Journal of Substance Abuse Treatment, 43, 313–321
   PubMed Web of Science ®Google Scholar
• Rhodes, T. (2002). The ‘risk environment': A framework for understanding and reducing drug-related harm. International Journal of Drug Policy, 13, 85–97
   Google Scholar
• Rhodes, T. (2009). Risk environments and drug harms: A social science for harm reduction approach. International Journal of Drug Policy, 20, 193–201
   PubMed Web of Science ®Google Scholar
• Rhodes, T., & Treloar, C. (2008). The social production of hepatitis C risk among injecting drug users: A qualitative synthesis. Addiction, 103, 1593–1603
   PubMed Web of Science ®Google Scholar
• Royer, M., Fuller, B.E., Ober, A., & Booth, R.E. (2004). HIV and HCV Counseling and Education (C&E) Intervention Training Manual, version 3.0 (NIH Publication No. 93-3580). Bethesda, MD: National Institute on Drug Abuse
   Google Scholar
• Ross, M.W., Wodak, A., Stowe, A., & Gold, J. (1994). Explanations for sharing injection equipment in injecting drug users and barriers to safer drug use. Addiction, 89, 473–479
   PubMed Web of Science ®Google Scholar
• Sobell, L.C., & Sobell, M.B. (1996). Timeline Followback user's guide: A calendar method for assessing alcohol and drug use. Toronto, Ontario, Canada: Addiction Research Foundation
   Google Scholar
• Strathdee, S.A., Galai, N., Safaiean, M., Celentano, D.D., Vlahov, D., Johnson, L., & Nelson, K.E. (2001). Sex differences in risk factors for HIV seroconversion among injection drug users: A 10-year perspective. Archives of Internal Medicine, 161, 1281–1288
   PubMed Web of Science ®Google Scholar
• Stryker, J., Coates, T.J., DeCarlo, P., Haynes-Sanstad, K., Shriver, M., & Makadon, H.J. (1995). Prevention of HIV infection: Looking back, looking ahead. Journal of the American Medical Association, 273, 1143–1148
   PubMed Web of Science ®Google Scholar
• Treloar, C., & Cao, W. (2005). Barriers to use of needle and syringe programmes in a high drug use area of Sydney, New South Wales. International Journal of Drug Policy, 16, 308–315
   Web of Science ®Google Scholar
• Vazan, P., Mateu-Gelabert, P., Cleland, C.M., Sandoval, M., & Friedman, S.R. (2012). Correlates of staying safe behaviors among long-term injection drug users: Psychometric evaluation of the Staying Safe Questionnaire. AIDS and Behavior, 16, 1472–1481
   PubMed Web of Science ®Google Scholar
• Vlahov, D., Sullivan, M., Astemborski, J., & Nelson, K.E. (1992). Bacterial infections and skin cleaning prior to injection among intravenous drug users. Public Health Reports, 107, 595–598
   PubMed Web of Science ®Google Scholar
• Williams, A.B. (1991). Women at risk: An AIDS educational needs assessment. Image: The Journal of Nursing Scholarship, 23, 208–213
   PubMedGoogle Scholar